As of August 28, 2026, Enliven Therapeutics, Inc. (ELVN) has a DilutionWatch DilutionScore of 16/100, rated LOW dilution risk. Enliven Therapeutics, Inc. has a market capitalization of $2.41B, 73.27M shares outstanding, 175 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for ELVN.
Market Data
Market Cap$2.41B
Shares Outstanding73.27M
Float44.42M
Cash$895.15M
Debt$302.0K
Short InterestN/A
Institutional Holdings
QoQ: ↑ 6.3% shares (2026Q1 vs prior)
175 institutional holders · 67.12M shares
#1
ORBIMED ADVISORS LLC
7.96M shares
#2
FMR LLC
6.83M shares
#3
Polar Capital Holdings Plc
5.07M shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest8.15M
Days to Cover11.4
% of Float18.4%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL CONVERTIBLE
2023-12-31
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual ELVN Dilution Snapshot
Enliven Therapeutics, Inc. (ELVN) has a DilutionScore of 16/100, rated Low dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for ELVN: xbrl on 2023-12-31.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track ELVN Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ELVN — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for ELVN
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.